Method of treating inflammatory bowel disease
AssigneeMetagenics, Inc.
InventorsNikhat Contractor, Jennifer Joan Ryan
Life of this patent
Estimating the term…
Abstract
A composition for treatment of inflammation in a mammal is provided. The mammal has a neutrophil to lymphocyte ratio (NLR). The composition includes a curcumagalactomannoside and a hops extract. The curcumagalactomannoside and the hops extract cooperate to decrease the NLR of the mammal 12 weeks after ingestion of the composition. A method of treatment of inflammation in a mammal is also provided. The method includes obtaining a parameter of the mammal. The method further includes dosing the composition based on the parameter. The method further includes administering the composition to the mammal.
Claims20
A composition for treatment of inflammation in a mammal, the mammal having a neutrophil to lymphocyte ratio (NLR), the composition comprising:
- a curcumagalactomannoside;
- and
- a hops extract;
- wherein the curcumagalactomannoside and the hops extract cooperate to decrease the NLR of the mammal 12 weeks after ingestion of the composition.
A composition for treatment of inflammation in a mammal, the mammal having a neutrophil to lymphocyte ratio (NLR), the composition consisting essentially of curcumagalactomannoside, a hops extract, a ginger root extract, a protein-containing matrix, a rosemary leaf extract, folate, vitamin B-12, and quercetin, wherein at least the curcumagalactomannoside and hops extract cooperate to decrease the NLR of the mammal 12 weeks after ingestion of the composition.
A method of treatment of inflammation in a mammal, the method comprising:
- obtaining a parameter of the mammal;
- dosing a composition based on the parameter, the composition comprising;
- a curcumagalactomannoside, and
- a hops extract;
- administering the composition to the mammal.
Dependencies are inferred from the claim text.